Professor Partnership Program Archives – Page 11 of 17

A study in mice tested the effectiveness of an oncolytic, or cancer-destroying, virus called Delta-24-ACT. The treatment group developed…

Personalized cancer treatment is on the rise. Cancer is not just one disease but thousands of different types and subtypes that each respond…

By analyzing cervical tissue of women who had hysterectomies, researchers found that the virus sets off a domino effect in the tissue that…

Scientists at H. Lee Moffitt Cancer Center and Research Institute recently completed a Phase 1 trial for a new therapy for non-small cell…

The Epstein Barr virus (EBV) infects over 90% of the adult population in the world and causes the disease commonly known as “mono” or…

Their original killer T cells had turned into special helper T cells with two abilities: killing invading cells and helping other immune…

Depression and anxiety are associated with breast cancer recurrence and mortality. However, anxiety is less associated with these outcomes…

A modified herpes virus is being tested for its ability to treat skin cancer, and it is predicted to work best when the tumors are small.

A recent study in mice demonstrated that "immunotherapy," using a special cell called a B7-H3 CAR T Cell, was able to shrink bone and brain…

Scientists have been developing vaccines to protect against disease for years. Most of these vaccines have been prophylactic, meaning they…